In consultation: Guidance and quality standards

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Consultation end date

Consultation end date

Type 1 selected

Type

Guidance programme

Guidance programme

Showing 1 to 10 of 14

TitleConsultationTypeConsultation end date
NICE Funding Variation Request ConsultationMethods / process manual consultationNICE process and methods
Ianalumab for treating active Sjogren's syndrome ID6634Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentatorsTechnology appraisal guidance
Daratumumab with bortezomib, lenalidomide and dexamethasone for untreated multiple myeloma when an autologous stem cell transplant is suitable [ID6249]Draft guidanceTechnology appraisal guidance
Nirogacestat for treating desmoid tumours [ID6453]Draft guidanceTechnology appraisal guidance
Modular update to NICE manuals: EQ-5D-5L value setNICE general consultationNICE general
Prostate cancer: diagnosis and management (update)ScopingNICE guideline
Sirolimus gel for treating facial angiofibroma from tuberous sclerosis complex in people 6 years and older (review of TA972) [ID6757]Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentatorsTechnology appraisal guidance
Epilepsies in children, young people and adultsDraft guidance consultationNICE guideline
Histamine dihydrochloride with interleukin-2 for maintenance treatment of acute myeloid leukaemia [ID1627]Draft guidanceTechnology appraisal guidance
Donidalorsen for preventing recurrent attacks of hereditary angioedema in people 12 years and over [ID6457]Draft guidanceTechnology appraisal guidance

Results per page

  1. 10
  2. 25
  3. 50
  4. All